ERAS Competitors & Alternatives
Compare Erasca Inc with similar stocks in the same industry
Biotechnology
ERAS
Main Stock$14.04
Tradestie Score
45
Market Cap
$626.91M
Analyst Upside
+71.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.90
|
$6.03B | - | 45 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.99
|
$6.02B | - | 66 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$156.07
|
$5.92B | - | 49 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.16
|
$5.80B | 19.3 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$320.13
|
$5.20B | 40.1 | 64 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$62.85
|
$4.94B | - | 42 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.04
|
$4.93B | - | 57 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$58.36
|
$4.84B | - | 60 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More ERAS Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry